Pulmonary Fibrosis
Pulmonary Fibrosis is an interstitial lung disease which causes excessive deposits of fibrotic tissues in the pulmonary interstitum. The average survival time after diagnosis varies between 2.5 and 3.5 years although some patients have lived more than a decade.
Symptoms
The symptoms of the disease are gradual and include difficulty breathing, a non-productive cough, disfigurement of the fingers, and a crackling sound in the lungs. It has long been noted that exposure to asbestos is a risk factor for the development of pulmonary fibrosis. Diagnosis of the disease can be determined by regular chest x-rays in tandem with high resolution CT scans that show the honeycombing fibrotic tissue.
Treatment Options
The treatment options for pulmonary fibrosis are limited, and there is currently no consensus on the best course of treatment. Although there is a great deal of ongoing research and debate in this field, as of yet no drugs have shown themselves to be effective in treating this condition. Lung transplantation is currently the only theraputic option available.
 |
 |
 |
Let Us Help!
If you have questions about asbestos or benzene exposure and are concerned about possible occupational diseases and cancers, Shelton Law Group is here to help. Call us today for a FREE evaluation to find out if you have a case or fill out our case assessment form to consult with a member of our devoted staff.